Matthew Shields, EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 16,195 shares at $32.87 ($532K) on 2026-06-03, disclosed to the SEC on 2026-06-04.
Scheduled sale ($532k) by EVP, Global Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2025-06-05 | $211K | — | Filing → |